Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,255 | -128,724 | -102,311 | -68,809 | -36,255 |
| Depreciation Amortization | -1,598 | -172 | 945 | 1,144 | 734 |
| Accounts receivable | -104 | -543 | -304 | -157 | -45 |
| Other Working Capital | 8,089 | 6,839 | 930 | -2,618 | 1,911 |
| Other Operating Activity | 13,300 | 49,007 | 37,832 | 25,279 | 12,641 |
| Operating Cash Flow | $-24,568 | $-73,593 | $-62,908 | $-45,161 | $-21,014 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -175 | -358 | -183 | -133 | -55 |
| Purchase Of Investment | -48,555 | -802,503 | -674,925 | -494,795 | -322,477 |
| Sale Of Investment | 134,126 | 408,016 | 258,766 | 111,020 | 9,620 |
| Investing Cash Flow | $85,396 | $-394,845 | $-416,342 | $-383,908 | $-312,912 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,265 | 11,827 | 8,408 | 5,709 | 4,844 |
| Common Stock Repurchased | -37,526 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,313 | 32,190 | 33,660 | -668 | -235 |
| Financing Cash Flow | $-37,574 | $44,017 | $42,068 | $5,041 | $4,609 |
| Beginning Cash Position | 71,308 | 495,729 | 495,729 | 495,729 | 495,729 |
| End Cash Position | 94,562 | 71,308 | 58,547 | 71,701 | 166,412 |
| Net Cash Flow | $23,254 | $-424,421 | $-437,182 | $-424,028 | $-329,317 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,568 | -73,593 | -62,908 | -45,161 | -21,014 |
| Capital Expenditure | -175 | -358 | -183 | -133 | -55 |
| Free Cash Flow | -24,743 | -73,951 | -63,091 | -45,294 | -21,069 |